VERA Vera Therapeutics Inc
Company Analysis
Latest News
🟢 Vera Therapeutics is trading 4.06% up today amid a broader biotech rally
Vera Therapeutics is trading 4.06% up now at $32.53 as biotechnology shares continue recovering after recent sector volatility. - No new company-specific...
🔴 Vera Therapeutics falls 4.3% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
Vera's FDA Review Win Sends Shares Surging — But Can a $425,000 Drug Survive a Crowded Kidney Market?
Shares jumped 10.3% to $31.86 after the FDA published an integrated review describing a favorable safety-and-efficacy profile for Vera Therapeutics' recently...
🟢 Vera Therapeutics is trading 10% up today after FDA review signals Trutakna’s competitive profile
Vera Therapeutics is trading 10.28% up now at $31.86 after the FDA published an integrated review describing a favorable profile for Trutakna, its recently...
🟢 Vera Therapeutics surges 10% after FDA publishes favorable review of Trutakna and investors reassess Q2 results
Vera Therapeutics (VERA) stock is trading 9.93% up at $31.76 today. - The surge follows the FDA's publication of a favorable integrated review of Trutakna, its...
🟢 Vera Therapeutics is trading 6% up today in pre-market following stronger August 13 U.S. market performance
Vera Therapeutics is trading at $30.54, up +5.71%, in pre-market on August 14, 2026, likely reflecting broader risk-on sentiment following stronger August 13,...
🟢 Vera Therapeutics is trading 11% up today in after-hours trading amid broader risk-on market sentiment
Vera Therapeutics is trading at $32.01 (+10.80%) after broader risk-on sentiment likely contributed to the gain. - The S&P 500 rose 0.72% and Nasdaq advanced...
🟢 Vera Therapeutics is trading 5.2% up in after-hours trading amid broader risk-on sentiment
Vera Therapeutics is trading at $30.38, up 5.16% in after-hours trading, in a move consistent with stronger risk appetite; no new company-specific announcement...
🟢 Vera Therapeutics is trading 6% up today in pre-market after narrower-than-expected Q2 loss
Vera Therapeutics is trading 5.65% up at $32.00 after its August 10, 2026, second-quarter update highlighted a narrower-than-expected $1.52-per-share loss. -...
🔴 Vera Therapeutics is trading 4.43% down today after a $109.5 million second-quarter net loss
Vera Therapeutics is trading 4.43% down at $30.18 after investors weighed its August 10 earnings report, which showed a $109.5 million second-quarter net loss...
Vera Therapeutics Beat Estimates and Launched Its First Drug — But Can a $425,000 Kidney Therapy Carve Out Space in a Six-Drug Market?
Shares jumped 6.1% to $33.50 after Vera Therapeutics posted second-quarter results that cleared a low bar while giving investors their first glimpse of life as...
🟢 Vera Therapeutics is trading 6% up in pre-market after second-quarter EPS beat
Vera Therapeutics is trading at $33.50 (+6.08%) after reporting second-quarter EPS of -$1.52 versus the -$1.60 analyst expectation. - Began the TRUTAKNA...
Vera Therapeutics beats second quarter 2026 EPS estimates as TRUTAKNA commercial launch begins
Vera Therapeutics reported a second quarter 2026 net loss of $109.5 million, or $1.52 per share, which narrowed from the $1.60 loss expected by analysts. While...
Vera Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Vera Therapeutics is expected to report a Q2 2026 loss of $1.60 per share on zero revenue, while the stock currently trades at $32.02 against an average...
🟢 Vera Therapeutics is trading 6.43% up today ahead of second-quarter results
Vera Therapeutics is trading at $32.30, up +6.43% during the August 6, 2026 session, with the move potentially reflecting positioning around scheduled...
🔴 Vera Therapeutics is trading 4.1% down today as investors turn cautious ahead of earnings
Vera Therapeutics is trading 4.08% down at $30.95 as investors turn cautious and adjust positions ahead of the company's August 6 earnings report. • The move...
Vera Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Vera Therapeutics is expected to report a Q2 2026 net loss of $1.60 per share on revenue of $1.28 million, with its current stock price of $35.45 trading...
🔴 Vera Therapeutics is trading 4.2% down today amid a broad biotech selloff
Vera Therapeutics is trading at $31.65 (down 4.2%) amid a broad selloff in the biotech sector and mixed overall market conditions. • The move appears driven...
🔴 Vera Therapeutics is trading 5.6% down today despite a broader biotech sector rally
Vera Therapeutics is trading 5.6% down at $33.24 today despite a lack of fresh news and a broader biotech sector rally. • The move appears to be driven by...
🔴 Vera Therapeutics is trading 4.1% down today on profit taking after its post-FDA approval rally
Vera Therapeutics is trading 4.1% down at $36.93 as the stock undergoes short-term profit taking and consolidation following a significant rally earlier this...